Innovative Eyewear Inc (LUCY): Nasdaq/NYSE listing notice — Innovative Eyewear receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

Innovative Eyewear Inc

Nasdaq notice on August 4, 2023 for non-compliance with minimum bid price rule (Listing Rule 5550(a)(2)).
Common stock bid price closed below $1.00 per share for 30 consecutive business days.
Company has 180 calendar days, until January 31, 2024, to regain compliance.
To cure, closing bid price must be at least $1.00 for 10 consecutive business days.
If not cured, may be eligible for additional 180-day period if other listing criteria are met.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Innovative Eyewear Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

August 4, 2023, Innovative Eyewear, Inc., a Florida corporation (the “ Company ”), received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2). which sets forth the minimum bid price requirement for continued listing on the Nasdaq Capital Market (the “ Minimum Bid Requirement ”) as the bid price of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), had closed below $1.00 per share for 30 consecuti

View on SEC.gov

Browse all listing & compliance notices →

Innovative Eyewear Inc filing history →

Source: SEC EDGAR

accession 0001829126-23-005296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.